Acute myeloid leukemia following chronic low-dose cyclophosphamide for metastatic breast cancer

Tumori

Volumn 87, Issue 2, 2001, Pages 101-103

  Sacco, C ^a   Patriarca, F ^a  

^a Dipartimento di Oncologia   (Italy)

Author keywords

Breast cancer; Cyclophosphamide; Di Bella multitherapy; Secondary leukemia

Indexed keywords

ALKYLATING AGENT; BUSULFAN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; GYRASE INHIBITOR; MELPHALAN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BREAST CANCER; BREAST METASTASIS; CANCER CHEMOTHERAPY; CASE REPORT; DI BELLA MULTITHERAPY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HUMAN; LATENT PERIOD; LEUKEMOGENESIS; LIVER METASTASIS; LONG TERM CARE; LUNG METASTASIS;

EID: 0034824962     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160108700207     Document Type: Article

References (17)

1. Evaluation of an unconventional treatment (the Di Bella multitherapy): Results of a phase II trial in Italy
2. Di Bella's therapy: The last word? The evidence would be stronger if the researchers had randomized their studies
3. The Di Bella multitherapy trial. Randomized controlled trials may not always be absolutely needed
4. Lessons from the Di Bella affair
5. The incidence of secondary leukemias
6. Association of cancer of the breast and acute myelocytic leukemia
7. Secondary acute leukemia. Report of the GIMEMA Archive of Adult Acute Leukemia
8. Colony formation in vitro by myelomonocytic leukemia cells
9. Risk of acute myelogenous leukaemia and myelodysplasia following cancer treatment
10. Carcinogenic effects of adjuvant tamoxifen treatment and radiotherapy for early breast cancer
11. Leukemia in breast cancer patients following adjuvant chemotherapy, or postoperative radiation: The NSABP experience
12. Adjuvant chemotherapy in early breast cancer and incidence of new primary malignancies
13. Leukemogenic potential of adjuvant chemotherapy for early-stage breast cancer: The Eastern Cooperative Oncology Group Experience
14. Treatment-related leukemia in breast cancer patients treated with fluorouracil-doxorubicin-cyclophosphamide combination adjuvant chemotherapy: The University of Texas M.D. Anderson Cancer Center Experience
15. Myelodysplasia and acute myeloid leukemia following adjuvant chemotherapy for breast cancer using mitoxantrone and methotrexate with or without mitomycin
16. Risk of leukemia after chemotherapy and radiation treatment for breast cancer
17. Secondary myelodysplasia and acute leukemia in breast cancer patients after autologous bone marrow transplantation